🇺🇸United States
Explosive growth in skin substitute spending with fraud
0
Definition
Medicare Part B spending on skin substitutes surpassed $10 billion annually by end of 2024, with an 83% increase in one year. Mobile wound care market shows costs averaging $23,000 per visit, often exceeding $100,000 per treatment. This unsustainable spending triggered regulatory crackdowns and arrests of providers for $900 million Medicare fraud.
Key Findings
- Financial Impact: $10+ billion Medicare Part B spending on skin substitutes (industry-wide)
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Mobile Wound Care Services in USA.
Deep Analysis (Premium)
Financial Impact
Data available with full access.
Unlock to reveal
Current Workarounds
Data available with full access.
Unlock to reveal
Get Solutions for This Problem
Full report with actionable solutions
$99$39
- Solutions for this specific pain
- Solutions for all 15 industry pains
- Where to find first clients
- Pricing & launch costs
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.
Related Business Risks
Unverified efficacy and patient harm from inappropriate treatment
Not quantified but includes litigation risk, regulatory fines, and patient harm liability
Excessive Skin Substitute Billing
$10B+
Skin Substitute Fraud Waste Abuse
$10B+ annually for Medicare
Medicare fraud liability from upcoding schemes
Variable - settlements range $45M-$309M
Explosive Medicare Part B spending scrutiny
Estimated $10,000,000,000+ market at risk
Kickback liability from rebate arrangements
Hundreds of millions per major distributor involved
Request Deep Analysis
🇺🇸 Be first to access this market's intelligence